Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board

By sjmartinez • June 27, 2024

Chawla SP, VAN Tine B, Federman N, Schwab J, Jones R, Subbiah V, Chawla NS, Afshar N, Hoos W, Feldman N, Spencer HT, Swaney W, Gordon EM. Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board. Anticancer Res. 2024 Jul;44(7):2765-2768. doi: 10.21873/anticanres.17139. PMID: 38925853.

Tags: cancer stem cell, CAR-T cell therapy, DeltaRex-G, Gene therapy, Hematology/Oncology, immunotherapy, osteosarcoma, personalized medicine, Publications, repurposed drugs, review

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm

De Botton S, Récher C, Cortes J, Curti A, Fenaux P, Peterlin P, Pigneux A, Yee K, Wei A, Mims A, Schiller G, Chao MM,[...]

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

Shore N, Nielsen SM, Esplin ED, Antonarakis ES, Barata PC, Beer TM, Beltran H, Bryce A, Cookson MS, Crawford ED, Dorff TB, George DJ, Heath[...]

Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Marshalek JP, Qing X, Dragan M, Tomassetti S. Retrospective Study of CD20 Expression Loss in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. J Hematol. 2024 Dec;13(6):268-277.[...]